SK36596A3 - Pyrido £3,2-e|pyrazinones with antiasthmatic effectivness and producing method thereof - Google Patents

Pyrido £3,2-e|pyrazinones with antiasthmatic effectivness and producing method thereof Download PDF

Info

Publication number
SK36596A3
SK36596A3 SK365-96A SK36596A SK36596A3 SK 36596 A3 SK36596 A3 SK 36596A3 SK 36596 A SK36596 A SK 36596A SK 36596 A3 SK36596 A3 SK 36596A3
Authority
SK
Slovakia
Prior art keywords
optionally substituted
amino
substituted
optionally
compounds
Prior art date
Application number
SK365-96A
Other languages
English (en)
Slovak (sk)
Inventor
Tm Fgen Norbert H
Thomas Buechner
Ute Achterrath-Tuckermann
Stefan Szelenyi
Bernhard Kutscher
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of SK36596A3 publication Critical patent/SK36596A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK365-96A 1995-03-24 1996-03-19 Pyrido £3,2-e|pyrazinones with antiasthmatic effectivness and producing method thereof SK36596A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510965A DE19510965A1 (de) 1995-03-24 1995-03-24 Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
SK36596A3 true SK36596A3 (en) 1997-02-05

Family

ID=7757727

Family Applications (1)

Application Number Title Priority Date Filing Date
SK365-96A SK36596A3 (en) 1995-03-24 1996-03-19 Pyrido £3,2-e|pyrazinones with antiasthmatic effectivness and producing method thereof

Country Status (30)

Country Link
US (1) US5723463A (pl)
EP (1) EP0736532B1 (pl)
JP (1) JP4124280B2 (pl)
KR (1) KR100401395B1 (pl)
CN (1) CN1058968C (pl)
AR (1) AR002039A1 (pl)
AT (1) ATE217624T1 (pl)
AU (1) AU697908B2 (pl)
BR (1) BR9601093A (pl)
CA (1) CA2172472C (pl)
CZ (1) CZ290784B6 (pl)
DE (2) DE19510965A1 (pl)
DK (1) DK0736532T3 (pl)
ES (1) ES2174989T3 (pl)
HR (1) HRP960129B1 (pl)
HU (1) HUP9600731A3 (pl)
IL (1) IL117621A (pl)
MX (1) MX9601069A (pl)
NO (1) NO307091B1 (pl)
NZ (1) NZ286232A (pl)
PL (1) PL184800B1 (pl)
PT (1) PT736532E (pl)
RU (1) RU2143433C1 (pl)
SG (1) SG43249A1 (pl)
SI (1) SI0736532T1 (pl)
SK (1) SK36596A3 (pl)
TR (1) TR199600217A2 (pl)
TW (1) TW426682B (pl)
UA (1) UA45319C2 (pl)
ZA (1) ZA962270B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19961302A1 (de) * 1999-12-18 2001-06-21 Dresden Arzneimittel Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen
KR20010101603A (ko) * 1999-01-20 2001-11-14 노왈드 이미다조[1,5-ａ]-피리도[3,2-ｅ]-피라지논의 약제로서의용도
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
US6465465B1 (en) 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
DE10012373A1 (de) * 2000-03-14 2001-09-20 Dresden Arzneimittel Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
EP2103613B1 (en) 2006-12-13 2016-02-17 ASKA Pharmaceutical Co., Ltd. Quinoxaline derivative
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
EA019085B1 (ru) 2007-09-14 2014-01-30 Янссен Фармасьютикалз, Инк. 1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
NZ584145A (en) 2007-09-14 2012-03-30 Ortho Mcneil Janssen Pharm 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1,4'] bipyridinyl-2'-ones
EP2205565B1 (en) * 2007-09-14 2013-04-17 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
MX2010005110A (es) * 2007-11-14 2010-09-09 Ortho Mcneil Janssen Pharm Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2.
EP2227472A1 (en) * 2007-11-30 2010-09-15 Elbion Gmbh Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
AU2008329775A1 (en) 2007-11-30 2009-06-04 Biotie Therapies Gmbh Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
MX2011005242A (es) 2008-11-28 2011-09-06 Ortho Mcneil Janssen Pharm Derivados de indol y benzoxazina como moduladores de los receptores de glutamato metabotropicos.
CA2760259C (en) 2009-05-12 2018-05-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
WO2015110435A1 (en) 2014-01-21 2015-07-30 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055465A (en) * 1989-05-31 1991-10-08 Berlex Laboratories, Inc. Imidazoquinoxalinones, their aza analogs and process for their preparation
US5166344A (en) * 1989-05-31 1992-11-24 Berlex Laboratories, Inc. Process for the preparation of imidazoquinoxalinones
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
WO1992022552A1 (en) * 1991-06-14 1992-12-23 The Upjohn Company IMIDAZO[1,5-a]QUINOXALINES
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
DE4228095A1 (de) * 1992-08-24 1994-03-03 Asta Medica Ag Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung
JP3252483B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 ３環性トリアゾロ誘導体の製造方法
JP3252484B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 ４，５−ジヒドロ［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体の製造方法
DE4329970A1 (de) * 1993-03-31 1994-10-06 Basf Ag Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
FR2704547B1 (fr) * 1993-04-30 1995-06-09 Adir Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
CN1041931C (zh) * 1993-05-06 1999-02-03 诺沃-诺迪斯克有限公司 [1,2,4]三唑并[4,3－a]喹喔啉化合物,它们的制备及其应用
CA2112290C (en) * 1993-12-23 2004-06-01 John R. Francis A clock recovery circuit for serial digital video
JP3240462B2 (ja) * 1996-05-24 2001-12-17 株式会社ケンウッド 光ディスク装置の光ピックアップサーボ装置

Also Published As

Publication number Publication date
US5723463A (en) 1998-03-03
ZA962270B (en) 1996-09-30
PL313434A1 (en) 1996-09-30
IL117621A (en) 1999-05-09
EP0736532B1 (de) 2002-05-15
ATE217624T1 (de) 2002-06-15
CA2172472C (en) 2000-01-18
CN1058968C (zh) 2000-11-29
HU9600731D0 (en) 1996-05-28
HRP960129A2 (en) 1997-08-31
TR199600217A2 (tr) 1996-10-21
NZ286232A (en) 1996-10-28
EP0736532A1 (de) 1996-10-09
HUP9600731A2 (en) 1997-01-28
SG43249A1 (en) 1997-10-17
CZ290784B6 (cs) 2002-10-16
BR9601093A (pt) 1998-01-06
IL117621A0 (en) 1996-07-23
CZ74796A3 (en) 1996-10-16
KR100401395B1 (ko) 2003-12-24
UA45319C2 (uk) 2002-04-15
AR002039A1 (es) 1998-01-07
RU2143433C1 (ru) 1999-12-27
HUP9600731A3 (en) 1997-04-28
PT736532E (pt) 2002-10-31
AU697908B2 (en) 1998-10-22
KR960034204A (ko) 1996-10-22
JP4124280B2 (ja) 2008-07-23
ES2174989T3 (es) 2002-11-16
NO307091B1 (no) 2000-02-07
HRP960129B1 (en) 2002-12-31
DK0736532T3 (da) 2002-09-02
JPH08269059A (ja) 1996-10-15
NO961173D0 (no) 1996-03-22
CN1140173A (zh) 1997-01-15
PL184800B1 (pl) 2002-12-31
TW426682B (en) 2001-03-21
CA2172472A1 (en) 1996-09-25
DE59609201D1 (de) 2002-06-20
NO961173L (no) 1996-09-25
SI0736532T1 (en) 2002-08-31
AU4825796A (en) 1996-10-03
MX9601069A (es) 1997-02-28
DE19510965A1 (de) 1996-09-26

Similar Documents

Publication Publication Date Title
SK36596A3 (en) Pyrido £3,2-e|pyrazinones with antiasthmatic effectivness and producing method thereof
KR100494347B1 (ko) 2-아릴-8-옥소디히드로푸린 유도체, 그의 제조방법, 이를함유하는 의약조성물, 및 이 화합물의 중간체
US4855298A (en) 6-Halo-1,2,3,4-tetrahydroquinazoline-4-spiro-4-imidazolidine-2,2'5'-triones useful for the treatment and prophylaxis of diabetic complications
JP4995203B2 (ja) 精神病および神経変性障害の処置のための、ｎ−ＡＣｈＲのコリン作動性リガンドとしての（１−アザ−ビシクロ［３．３．１］ノン−４−イル）−［５−（１Ｈ−インドール−５−イル）−ヘテロアリール］−アミン
AU671836B2 (en) Fused imidazole and triazole derivatives as 5-HT1 receptor agonists
AU2005261866A1 (en) 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-NACHR ligands for the treatment of CNS diseases
MXPA97002658A (en) Novedous derivatives of carboxyl acid, supreparation and
WO1992007830A2 (en) Oxindole peptide antagonists
SK171197A3 (en) 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
NZ230068A (en) Indazole-3-carboxylic acid esters and amides of diaza compounds having 6,7, or 8 ring members: preparatory processes and pharmaceutical compositions
CA2400657A1 (en) Derivatives of quinoline as alpha-2 antagonists
CA2108800A1 (en) Substituted (pyridinylamino)-benzisoxazoles and -benzoisothiazoles, a process for their preparation and their use as medicaments
MXPA00003390A (es) Derivado de tiazolbenzoimidazol novedoso.
HU190573B (en) Process for producing new beta-carboline derivatives and pharmaceutical compositions cintaining them
HU207863B (en) Process for producing n-/phenyl-oxy-alkyl/-3-heteroaryl-8-aza-bicyclo-/3.2.1/octanes and pharmaceutical compositions containing them
SK42299A3 (en) N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
US5512590A (en) 5,6-dihydro-4h-imidazo 2',1':2,3!imidazo- 4,5,1-ij!quinoline and 4,5-dihydroimidazo- 1,2-a!pyrolo 1,2,3-cd!benzimidazole derivatives, their preparation and application in therapeutics
PT88326B (pt) Processo para a preparacao de novos derivados do benzimidazol
US4292323A (en) Phenyl-1,2,3,4-tetrahydrocarbazoles and use thereof
EP0661273B1 (en) Indane derivatives and processes for preparing the same
US20080293688A1 (en) Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
CA2112555A1 (en) 2-thienylimidazo[2,1-b]benzothiazole-3-acetic acid derivatives, their preparation and their use
FI78465C (fi) Foerfarande foer framstaellning av terapeutiskt verkande -oxo- -karbamoylpyrrolpropionitriler.
MXPA00005415A (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
CZ20001981A3 (cs) 2-Aryl-8-oxodihydropurinové deriváty, způsob jejich přípravy, farmaceutické prostředky které je obsahují a jejich meziprodukty